The drug discovery segment is well on its way to market leadership, with North America emerging as the most important regional market

Global RNA Analysis/Transcriptomics Market

Dublin, August 19, 2024 (GLOBE NEWSWIRE) — The report “RNA Analysis / Transcriptomics – Global Strategic Business Report” has been added to The Offer.

The global RNA Analysis/Transcriptomics market is valued at USD 7.9 billion in 2023 and is expected to reach USD 19.0 billion by 2030, growing at a CAGR of 13.3% between 2023 and 2030. This comprehensive report offers in-depth analysis of market trends, drivers, and forecasts to help you make informed business decisions.

The growth in the RNA analysis/transcriptomics market is driven by several factors including the increasing demand for personalized medicine, advancements in sequencing technologies, and the rising prevalence of chronic diseases and cancer. The transition to personalized medicine, which aims to tailor treatments based on an individual's genetic profile, has increased the need for comprehensive transcriptomics analysis to identify disease-specific biomarkers and therapeutic targets.

Continuous improvements in sequencing technologies leading to higher accuracy, throughput and cost-effectiveness have made transcriptomic studies more accessible and feasible for a wider range of applications. In addition, the rising incidence of chronic diseases and cancers has increased the focus on understanding the molecular basis of these diseases and has driven the adoption of transcriptomics in research and clinic.

Government initiatives and funding for genomic research, as well as collaborations between academic institutions and pharmaceutical companies, are also contributing to the expansion of the market. As a result, the field of RNA analysis/transcriptomics is poised for significant growth, with ongoing innovations and applications promising to advance our understanding of biology and improve healthcare outcomes.

Key findings:

• Market Growth: Understand the significant growth curve of the RNA Analysis/Transcriptomics Reagents/Consumables segment, which is expected to reach $9.7 billion by 2030 at a CAGR of 14.4%. The RNA Analysis/Transcriptomics Instruments segment is also expected to grow at a CAGR of 11.8% during the analysis period.

• Regional Analysis: Gain insights into the US market, estimated to reach $2.9 billion in 2023, and China, which is forecast to grow at an impressive CAGR of 14.3% per year to reach $1.6 billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and Asia Pacific.

Reporting features:

• Comprehensive market data: Independent analysis of annual sales and market forecasts in millions of US dollars from 2023 to 2030.

• Detailed Regional Analysis: Detailed insights into key markets including the US, China, Japan, Canada, Europe, Asia Pacific, Latin America, Middle East and Africa.

• Company Profiles: Coverage of major players such as Agilent Technologies, Inc., Beckman Coulter, Inc., bioMerieux SA and more.

• Free Updates: Get free report updates for one year to stay informed of the latest market developments.

Main features:

MARKET OVERVIEW

• Global economic update

• RNA-oriented projects will increase

• Competition

• RNA Analysis/Transcriptomics – Percentage Market Share of Major Competitors Worldwide in 2024 (D)

• Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

• What is RNA-Seq technology?

• A prelude to transcriptomics technologies

• Global market outlook and prospects

• PCR is becoming the leading technology

• The drug discovery segment is expected to lead the global market

• North America is becoming the most important regional market

• Global brands

• Recent market activity

MARKET TRENDS & DRIVERS

• Trend towards personalized medicine drives market growth

• Global personalized medicine market

• Drug ineffectiveness for selected therapy categories as a percentage of the patient population

• Given the increasing prevalence of chronic diseases, transcriptomics is becoming increasingly important

• Deaths from heart disease: Estimated percentage breakdown for cardiovascular disease, ischemic heart disease, stroke and others

• Applications of transcriptomics in disease and diagnostic profiling

• Increasing PCR applications in the biotechnology sector

• Progressive growth of Omics technologies: opportunity for the RNA analysis/transcriptomics market

• The growing role of transcriptomics in oncology

• RNA sequencing crucial for cancer and rare diseases

• Large-scale RNA sequencing and single-cell RNA sequencing for cardiovascular research

• Bulk RNA sequencing

• Single cell sequencing

• Spatial transcriptomics

• Single-cell RNA-Seq technologies are experiencing steady growth

• The development of scRNA-seq

• Growth of long read transcriptome sequencing

• scRNA-seq for autoimmune inflammatory rheumatic diseases

• SPLiTseq is helpful in understanding the cause of disease

• Gene expression microarray technology is gaining ground

• Microfluidic-based droplet technologies are experiencing growth

• inDrops approach shows growth

• The spatial transcriptomics market is experiencing significant growth

• Spatial transcriptomic data analysis

• Next-generation sequencing provides greater accuracy for transcriptomics activities

• Single-cell NGS is experiencing rapid growth

• Advantages of RNA sequencing boost market prospects

• Blood transcriptome sequencing to identify genes for rare diseases

• Increasing focus on toxicogenomics: potential for RNA analysis/transcriptomics markets

• Increasing R&D spending in pharmaceuticals and biotechnology offers opportunities

• Global pharmaceutical research and development spending (billion USD) 2015-2025

• Technological advances and innovations drive market growth

• Sci-Plex – A new technique for profiling gene expression in single cells

• Launch of Oxford Nanopore’s innovative portable sequencer for sequencing long reads and RNA molecules improves transcriptome analysis

• RNA-Combine, a toolkit for more comprehensive analysis of transcriptome data

• Ageing population structure offers opportunities for transcriptomics technologies

• Challenges for the RNA/transcriptomics market

Focus on selected players(Total 115 presented)

• Agilent Technologies, Inc.

• Beckman-Coulter, Inc.

• BioMerieux SA

• Analytik Jena AG

• Ambry Genetics

• Advanced Cell Diagnostics, Inc.

• Bioneer Corporation

• BioChain Institute, Inc.

• Akoya Biosciences, Inc.

• Akobiom

• ADS Biotec, Inc.

• BGI Genomics Co Ltd.

• 10X Genomics

• Biois Co Ltd

• Bertin Technologies, Sas

For more information about this report visit https://www.researchandmarkets.com/r/cxysj1

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900